Delivery Order SPE2DX22D0010-SPE2D826FAZ20
Award Date 11/11/25
Potential Completion Date 11/12/25
Potential Value $8.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a competitive delivery order valued at $1,971.30 to AmerisourceBergen Drug Corp for the supply of Quillivant XR 25 mg/5 ml suspension in 120 ml quantities. The award, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a firm fixed price transaction with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $2,544.36 to AmerisourceBergen Drug Corp for the supply of Quillivant XR 25 mg/5 mL suspension in 60 mL quantities. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by August 11, 2025. The product will be sourced from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,223.58 to supply Quillivant XR 25 mg/5 mL suspension in 150 mL quantities. This is a firm fixed price delivery order with an ultimate completion date of September 24, 2025, issued under a non-set-aside competitive procurement. AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, will perform the work at that same location. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,577.04 for Quillivant XR 25 mg/5 mL suspension (180 mL), with an ultimate completion date of June 27, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded through open competition. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- The Defense Logistics Agency awarded a delivery order valued at $1,314.20 to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 mL oral suspension (180 mL) on November 6, 2025, with completion scheduled for November 7, 2025. This firm fixed price, non-set-aside delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order...
- The Defense Logistics Agency awarded a $2,442.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 ml suspension (120 ml), with an ultimate completion date of October 24, 2025. This non-set-aside contract represents a competitively awarded delivery order under AmerisourceBergen's existing pharmaceutical supply vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension (60 mL) with a ceiling value of $1,431.19. This is a firm fixed-price, non-set-aside delivery order that will be fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of November 6, 2025. The delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,648.22 firm fixed price delivery order to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 ml suspension (120 ml), with an ultimate completion date of November 5, 2025. This non-set-aside contract represents a single pharmaceutical delivery under the company's broader federal supply arrangements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,481.28 to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 ml suspension (180 ml), with an ultimate completion date of November 7, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The product will be performed and delivered from the contractor's location...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,679.33 for Quillivant XR 25 mg/5 ml suspension (150 ml) by the Defense Logistics Agency's Medical Supply Chain on September 25, 2025, with completion scheduled for September 26, 2025. The contract utilizes firm fixed pricing and carries no set-aside designation, indicating competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...